Cargando…
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
SARS-CoV-2 is a novel coronavirus that severely affects the respiratory system, is the cause of the COVID-19 pandemic, and is projected to result in the deaths of 2 million people worldwide. Recent reports suggest that SARS-CoV-2 also affects the central nervous system along with other organs. COVID...
Autores principales: | Amruta, Narayanappa, Chastain, Wesley H., Paz, Meshi, Solch, Rebecca J., Murray-Brown, Isabel C., Befeler, Jaime B., Gressett, Timothy E., Longo, Michele T., Engler-Chiurazzi, Elizabeth B., Bix, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894219/ https://www.ncbi.nlm.nih.gov/pubmed/33674185 http://dx.doi.org/10.1016/j.cytogfr.2021.02.002 |
Ejemplares similares
-
In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice
por: Amruta, Narayanappa, et al.
Publicado: (2021) -
Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory Mice
por: Amruta, Narayanappa, et al.
Publicado: (2022) -
Perlecan: a review of its role in neurologic and musculoskeletal disease
por: Lavorgna, Tessa R., et al.
Publicado: (2023) -
Effect of acetic acid inactivation of SARS-CoV-2
por: Amruta, Narayanappa, et al.
Publicado: (2023) -
ATN-161 Ameliorates Ischemia/Reperfusion-induced Oxidative Stress, Fibro-inflammation, Mitochondrial damage, and Apoptosis-mediated Tight Junction Disruption in bEnd.3 Cells
por: Amruta, Narayanappa, et al.
Publicado: (2021)